Nanomix Inc. has initiated clinical testing in the United States to evaluate the omega-3 cardiac panel. The panel quantitatively tests whole blood specimens for levels of cardiac troponin I (cTnI), myoglobin and H-FABP, biomarkers often used as an aid in the diagnosis of myocardial infarction (MI). The initial testing will be conducted with approximately 170 normally healthy subjects and will provide baseline performance information that will form the basis of future registration clinical studies.

The Massachusetts General Hospital officially announced the launch of the Mass General Institute for Heart, Vascular and Stroke Care, one of the only institutes in the world to integrate cardiovascular and cerebrovascular care.

Colibri Heart Valve LLC has successfully completed the first clinical use of the company's proprietary transcatheter aortic heart valve. The Colibri transcatheter aortic valve implantation (TAVI) system is the world's first and only low profile, 14 French pre-mounted, pre-crimped, and pre-packaged, ready-for-use, TAVI system. These advantages are designed to reduce delivery profile along with a reduction in preparation and insertion time, which are not available in any other device, either currently available or in known development.

The Society for Cardiovascular Angiography and Interventions (SCAI) reports on the “Ten Do’s and Don’ts for Improving Documentation in the Catheterization (Cath) Lab” based on studies by the Accreditation for Cardiovascular Excellence (ACE).

Lantheus Medical Imaging has entered into a new agreement with Fujifilm RI Pharma (FRI) to license and distribute Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) and Neurolite (Kit for the Preparation of Technetium Tc99m Bicisate for Injection) in Japan.

SunTech Medical’s noninvasive blood pressure products have successfully passed multiple interoperability tests during 2013 Integrating the Healthcare Enterprise (IHE) North American Connectathon (Chicago, Ill.) — part of the company’s strategy to develop medical products that can easily share data with different electronic healthcare management (EMR) systems.

Researchers from Boston University School of Medicine (BUSM) have shown that using magnetic resonance imaging (MRI) to measure blood flow over atherosclerotic plaques could help identify plaques at risk for thrombosis. The findings, which appear in the March issue of Circulation Cardiovascular Imaging, offer a non-invasive application in the diagnosis and treatment of patients with atherosclerosis.

An estimated 5,000 nuclear medicine and molecular imaging professionals are expected to gather in June for the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) to discuss the latest advances in radiotracers, imaging modalities, radionuclide therapies and quality.